Patent
   D674893
Priority
Oct 20 2011
Filed
Oct 20 2011
Issued
Jan 22 2013
Expiry
Jan 22 2027
Assg.orig
Entity
unknown
49
13
n/a
The ornamental design for an inhaler device, as shown and described.

FIG. 1 is a front perspective view of an inhaler device of our design.

FIG. 2 is a rear perspective view of the inhaler device of FIG. 1.

FIG. 3 is a bottom perspective view of the inhaler device of FIG. 1.

FIG. 4 is a top view of the inhaler device of FIG. 1.

FIG. 5 is a bottom view of the inhaler device of FIG. 1.

FIG. 6 is a first side view of the inhaler device of FIG. 1.

FIG. 7 is a second side view of the inhaler device of FIG. 1.

FIG. 8 is a front view of the inhaler device of FIG. 1; and,

FIG. 9 is a rear view of the inhaler device of FIG. 1.

The broken lines immediately adjacent the shaded areas represent the bounds of the claimed design while all other broken lines are directed to environment and are for illustrative purposes only; the broken lines form no part of the claimed design.

Kinsey, P. Spencer, Adamo, Benoit

Patent Priority Assignee Title
10130581, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10130685, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
10130709, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
10143655, Sep 14 2005 MannKind Corporation Method of drug formulation
10159644, Oct 26 2012 MannKind Corporation; TechnoVax, Inc. Inhalable vaccine compositions and methods
10172850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
10201672, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10258664, Oct 24 2011 MannKind Corporation Methods and compositions for treating pain
10307464, Mar 27 2015 MannKind Corporation Use of ultrarapid acting insulin
10342938, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
10421729, Mar 15 2013 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
10561806, Oct 02 2014 MannKind Corporation Mouthpiece cover for an inhaler
10625034, Apr 01 2011 MannKind Corporation Blister package for pharmaceutical cartridges
10675421, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
10751488, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
11446127, Aug 05 2013 MannKind Corporation Insufflation apparatus and methods
9339615, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9346766, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9364436, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
9446001, Sep 14 2005 MannKind Corporation Increasing drug affinity for crystalline microparticle surfaces
9446133, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9511198, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9610351, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9630930, Jun 12 2009 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
9655850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9662461, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9675674, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
9700690, Mar 20 2002 MannKind Corporation Inhalation apparatus
9706944, Nov 03 2009 MannKind Corporation Apparatus and method for simulating inhalation efforts
9717689, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9796688, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9801925, Jun 29 1999 MannKind Corporation Potentiation of glucose elimination
9802012, Jul 12 2012 MannKind Corporation Dry powder drug delivery system and methods
9925144, Jul 18 2013 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
9943571, Aug 11 2008 MannKind Corporation Use of ultrarapid acting insulin
9983108, Mar 11 2009 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
D692140, Apr 13 2012 Advent Consumer Healthcare LLC Breath flow meter
D724592, Feb 21 2014 Amazon Technologies, Inc Scanner device
D742503, Jan 12 2011 Vectura GmbH Mobile inhaler device
D769438, Jan 08 2014 Glaxo Group Limited Inhaler device
D781412, Apr 09 2015 Inhaler
D814019, Jan 08 2014 Glaxo Group Limited Inhaler device
D824015, Jan 29 2016 MannKind Corporation Inhaler
D824016, Jan 29 2016 MannKind Corporation Inhaler
D824510, Jan 29 2016 MannKind Corporation Inhaler
D834178, May 19 2017 MannKind Corporation Inhaler
D841798, Jan 29 2016 MannKind Corporation Inhaler
D851748, Nov 08 2017 MannKind Corporation Inhaler
D898187, May 21 2019 RECEPTOR HOLDINGS, INC. Inhaler device
Patent Priority Assignee Title
7305986, Jul 23 1999 MannKind Corporation Unit dose capsules for use in a dry powder inhaler
7464706, Jul 23 1999 MannKind Corporation; ManKind Corporation Unit dose cartridge and dry powder inhaler
8215300, Jul 23 1999 MannKind Corporation Unit dose cartridge and dry powder inhaler
20040182387,
20080053437,
20080127970,
20090308390,
20090308391,
20090308392,
20120174923,
D597657, Jun 13 2008 MannKind Corporation Dry powder inhaler
D614760, Jun 13 2008 MannKind Corporation Dry powder inhaler
D636868, Jun 14 2010 MannKind Corporation Dry powder inhaler
/////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 20 2011MannKind Corporation(assignment on the face of the patent)
Nov 08 2011ADAMO, BENOITMannKind CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0271990600 pdf
Nov 08 2011KINSEY, P SPENCERMannKind CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0271990600 pdf
Jul 01 2013MannKind CorporationHORIZON SANTE FLML SARLSECURITY AGREEMENT0307400123 pdf
Jul 01 2013MannKind CorporationDEERFIELD PRIVATE DESIGN INTERNATIONAL II, L P SECURITY AGREEMENT0307400123 pdf
Jul 01 2013MannKind CorporationDEERFIELD PRIVATE DESIGN FUND II, L P SECURITY AGREEMENT0307400123 pdf
Sep 23 2014MannKind CorporationAVENTISUB LLCPATENT SECURITY AGREEMENT0338310110 pdf
Nov 09 2016AVENTISUB LLCMannKind CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0405880008 pdf
Aug 06 2019MannKind CorporationMIDCAP FINANCIAL TRUST, AS AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0500440181 pdf
Aug 06 2019HORIZON SANTE FLML SARLMannKind CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0500440138 pdf
Aug 06 2019DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L P MannKind CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0500440138 pdf
Aug 06 2019DEERFIELD PRIVATE DESIGN FUND II, L P MannKind CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0500440138 pdf
Apr 01 2024MIDCAP FINANCIAL TRUST, AS AGENTMannKind CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0670240082 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule